Richard G. Horan

About

Mr. Horan joined Slater in January 2002 as Executive Director of the Slater Center for Biomedical Technologies (“Slater Biomed”). In March 2005, Slater Biomed merged with four other entities comprising the Slater Program and was re-named the Slater Technology Fund. Effective with the merger, Mr. Horan was appointed Senior Managing Director. Mr. Horan began his career in the investment banking business in 1980, when he joined the Capital Markets Group of BankAmerica, San Francisco, CA. In 1986, Mr. Horan joined the venture capital firm of Johnston Associates in Princeton, NJ, one of the original seed stage investors in the field of biotechnology and life sciences. In 1998, Mr. Horan founded Sachem Ventures LLC, an independent seed stage venture development firm which focused in life science and healthcare markets. During his tenure in the venture capital business, Mr. Horan has served as CEO of several of his portfolio companies, including: Immunicon Corp. (NASDAQ: IMMC), a Phila

Investment Focus

Location

Hanover, US